Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „ipilimumab“
Suchtreffer
Begriffe & Kennungen
Opdivo · 4.8 · In patients treated with nivolumab in combination with ipilimumab (with or without chemotherapy), the incidenc
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with ipilimumab (with or without chemotherapy), the incidenc
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with ipilimumab (with or without chemotherapy), the incidenc
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with ipilimumab (with or without chemotherapy), the incidenc
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with ipilimumab (with or without chemotherapy), the incidenc
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with ipilimumab (with or without chemotherapy), the incidenc
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with ipilimumab (with or without chemotherapy), the proporti
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with ipilimumab (with or without chemotherapy), the proporti
Eintrag öffnenOpdivo · 4.8 · Nivolumab as monotherapy or nivolumab in combination with ipilimumab The safety of nivolumab as monotherapy (3
Eintrag öffnenOpdivo · 4.8 · Nivolumab in combination with ipilimumab (with or without chemotherapy) In the pooled dataset of nivolumab adm
Eintrag öffnenOpdivo · 4.8 · Nivolumab in combination with ipilimumab (with or without chemotherapy) In the pooled dataset of nivolumab adm
Eintrag öffnenOpdivo · 4.8 · Of the patients who were treated with nivolumab in combination with ipilimumab and chemotherapy and evaluable
Eintrag öffnenOpdivo · 4.8 · Of the patients who were treated with nivolumab in combination with ipilimumab and chemotherapy and evaluable
Eintrag öffnenOpdivo · 4.8 · Of the patients who were treated with nivolumab in combination with ipilimumab and evaluable for the presence
Eintrag öffnenOpdivo · 4.8 · Of the patients who were treated with nivolumab in combination with ipilimumab and evaluable for the presence
Eintrag öffnenOpdivo · 4.8 · The safety of nivolumab as monotherapy (3 mg/kg every 2 weeks) and in combination with ipilimumab (3 mg/kg niv
Eintrag öffnenYervoy · 4.5 · 21 A drug-interaction study in adults of ipilimumab administered alone and in combination with chemotherapy (d
Eintrag öffnenYervoy · 4.5 · Corticosteroids The use of systemic corticosteroids at baseline, before starting ipilimumab, should be avoided
Eintrag öffnenYervoy · 4.5 · Ipilimumab is a human monoclonal antibody that is not metabolised by cytochrome P450 enzymes (CYPs) or other d
Eintrag öffnenYervoy · 4.8 · 31 Immunogenicity Less than 2% of patients with advanced melanoma who received ipilimumab in Phase 2 and 3 cli
Eintrag öffnen